Patent · US Active

Label-free detection of renal cancer

US9410949B2 · kind B2 · utility

15Cited by
4References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2011
Grant dateAug 9, 2016
Priority date
Expiry dateSep 25, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2201/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Natural and/or synthetic antibodies for specific proteins are adhered to nanoparticles. The nanoparticles are adhered to a substrate and the substrate is exposed to a sample that may contain the specific proteins. The substrates are then tested with surface enhanced Raman scattering techniques and/or localized surface plasmon resonance techniques to quantify the amount of the specific protein in the sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.